Search Results - "de Fijter, JW"

Quality of Life before and after the Start of Dialysis in Older Patients by de Rooij, Esther N M, Meuleman, Yvette, de Fijter, Johan W, Le Cessie, Saskia, Jager, Kitty J, Chesnaye, Nicholas C, Evans, Marie, Pagels, Agneta A, Caskey, Fergus J, Torino, Claudia, Porto, Gaetana, Szymczak, Maciej, Drechsler, Christiane, Wanner, Christoph, Dekker, Friedo W, Hoogeveen, Ellen K

“…In older people with kidney failure, improving health-related quality of life is often more important than solely prolonging life. However, little is known…”
Get full text

Comparing Mycophenolate Mofetil Regimens for de Novo Renal Transplant Recipients : The Fixed-Dose Concentration-Controlled Trial by VAN GELDER, Teun, TEDESCO SILVA, Helio, OELLERICH, Michael, HOLT, David W, TÖNSHOFF, Burkhard, KEOWN, Paul, CAMPBELL, Scott, MAMELOK, Richard D, DE FIJTER, Johan W, BUDDE, Klemens, KUYPERS, Dirk, TYDEN, Gunnar, LOHMUS, Aleksander, SOMMERER, Claudia, HARTMANN, Anders, LE MEUR, Yann

“…Fixed-dose mycophenolate mofetil (MMF) reduces the incidence of acute rejection after solid organ transplantation. The Fixed-Dose Concentration Controlled…”
Get full text

Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial by Bredewold, Obbo W., Chan, Joe, Svensson, My, Bruchfeld, Annette, de Fijter, Johan W., Furuland, Hans, Grinyo, Josep M., Hartmann, Anders, Holdaas, Hallvard, Hellberg, Olof, Jardine, Alan, Mjörnstedt, Lars, Skov, Karin, Smerud, Knut T., Soveri, Inga, Sørensen, Søren S., Zonneveld, Anton-Jan van, Fellström, Bengt

“…In kidney transplant recipients (KTRs), a belatacept-based immunosuppressive regimen is associated with beneficial effects on cardiovascular (CV) risk factors…”
Get full text

Randomized Trial Comparing Late Concentration-Controlled Calcineurin Inhibitor or Mycophenolate Mofetil Withdrawal by MOURER, Jacqueline S, DEN HARTIGH, Jan, VAN ZWET, Erik W, MALLAT, Marko J. K, DUBBELD, Jeroen, DE FIJTER, Johan W

“…Early calcineurin inhibitor (CNI) withdrawal with mycophenolate mofetil (MMF) has not become routine practice, due to concerns about excess acute rejection…”
Get full text

Effect of CYP3A422, CYP3A53, and CYP3A Combined Genotypes on Cyclosporine, Everolimus, and Tacrolimus Pharmacokinetics in Renal Transplantation by Moes, DJAR, Swen, JJ, Hartigh, J, Straaten, T, Heide, JJ Homan, Sanders, JS, Bemelman, FJ, Fijter, JW, Guchelaar, HJ

“…Cyclosporine, everolimus, and tacrolimus are the cornerstone of immunosuppressive therapy in renal transplantation. These drugs are characterized by narrow…”
Get full text

The pathobiology of chronic allograft nephropathy: Immune-mediated damage and accelerated aging by Joosten, Simone A., van Kooten, Cees, Sijpkens, Yvo W.J., de Fijter, Johan W., Paul, Leendert C.

“…The pathobiology of chronic allograft nephropathy: Immune-mediated damage and accelerated aging. Chronic allograft nephropathy includes chronic calcineurin…”
Get full text

Symptom Burden before and after Dialysis Initiation in Older Patients by de Rooij, Esther N M, Meuleman, Yvette, de Fijter, Johan W, Jager, Kitty J, Chesnaye, Nicholas C, Evans, Marie, Caskey, Fergus J, Torino, Claudia, Porto, Gaetana, Szymczak, Maciej, Drechsler, Christiane, Wanner, Christoph, Dekker, Friedo W, Hoogeveen, Ellen K

“…For older patients with kidney failure, lowering symptom burden may be more important than prolonging life. Dialysis initiation may affect individual kidney…”
Get full text

Effect of obesity on the outcome of kidney transplantation: a 20-year follow-up by Hoogeveen, Ellen K, Aalten, Jeroen, Rothman, Kenneth J, Roodnat, Joke I, Mallat, Marko J K, Borm, George, Weimar, Willem, Hoitsma, Andries J, de Fijter, Johan W

“…Cardiovascular disease is both a major threat to the life expectancy of kidney transplant recipients and an important determinant of late allograft loss…”
Get full text

Attenuation of Torque teno viral load over time in kidney transplantation recipients treated with calcineurin inhibitors is mitigated after conversion to belatacept by Bredewold, O. W., Moest, W. T., Fijter, J. W., Meijers, E., Bruchfeld, A., Skov, K., Svensson, M. H. S., Chan, J., Mjornstedt, L., Sorensen, S. S., Fellstrom, B., Feltkamp, M. C. W., Zonneveld, A. J., Rotmans, J. I.

“…Torque Teno Virus (TTV) is a non‐pathogenic anellovirus, highly prevalent in healthy populations. Variations in its viral load have been associated with states…”
Get full text

Subsequent Squamous- and Basal-Cell Carcinomas in Kidney-Transplant Recipients After the First Skin Cancer: Cumulative Incidence and Risk Factors by WISGERHOF, Hermina C, EDELBROEK, Jeroen R. J, DE FIJTER, Johan W, HAASNOOT, Geert W, CLAAS, Frans H. J, WILLEMZE, Rein, BOUWES BAVINCK, Jan N

“…The risk of skin cancer is highly increased in kidney-transplant recipients (KTR), but the risk of subsequent skin cancers is less well studied. The aim of…”
Get full text

Mannan‐Binding Lectin Mediates Renal Ischemia/Reperfusion Injury Independent of Complement Activation by van der Pol, P., Schlagwein, N., van Gijlswijk, D. J., Berger, S. P., Roos, A., Bajema, I. M., de Boer, H. C., de Fijter, J. W., Stahl, G. L., Daha, M. R., van Kooten, C.

“…Ischemia/reperfusion injury (IRI) remains a major problem in renal transplantation. Clinical studies have identified that high serum levels of Mannan‐binding…”
Get full text

Risk factors for Pneumocystis jiroveciipneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis by de Boer, MGJ, Kroon, F P, le Cessie, S, de Fijter, JW, van Dissel, JT

“…M.G.J. de Boer, F.P. Kroon, S. le Cessie, J.W. de Fijter, J.T. van Dissel. Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients…”
Get full text

KIR‐Ligand Mismatches Are Associated With Reduced Long‐Term Graft Survival in HLA‐Compatible Kidney Transplantation by van Bergen, J., Thompson, A., Haasnoot, G. W., Roodnat, J. I., de Fijter, J. W., Claas, F. H. J., Koning, F., Doxiadis, I. I. N.

“…Natural killer (NK) cells are cytotoxic lymphocytes of the innate immune system with the ability to detect HLA class I disparities via killer‐cell…”
Get full text

SYMPTOM BURDEN AND INDIVIDUAL SYMPTOMS BEFORE AND AFTER DIALYSIS INITIATION IN OLDER PATIENTS by De Rooij, E, Meuleman, Y, De Fijter, JW, Jager, KJ, Chesnaye, N, Evans, M, Pagels, A, Caskey, F, Torino, C, Porto, G, Szymczak, M, Drechsler, C, Wanner, C, Dekker, FW, Hoogeveen, E

Get full text

Randomized Trial of Short‐Course High‐Dose Erythropoietin in Donation After Cardiac Death Kidney Transplant Recipients by Aydin, Z., Mallat, M. J. K., Schaapherder, A. F. M., van Zonneveld, A. J., van Kooten, C., Rabelink, T. J., de Fijter, J. W.

“…Eryhropoiesis‐stimulating agents have demonstrated tissue‐protective effects in experimental models of ischemia‐reperfusion injury. PROTECT was a 12‐month,…”
Get full text

HEALTH-RELATED QUALITY OF LIFE (HRQOL) AND SYMPTOM BURDEN BEFORE AND AFTER START OF DIALYSIS IN OLDER PATIENTS by De Rooij, E, Meuleman, Y, De Fijter, JW, Jager, KJ, Chesnaye, N, Evans, M, Caskey, F, Torino, C, Szymczak, M, Drechsler, C, Wanner, C, Dekker, FW, Hoogeveen, E

Get full text

AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipients by Scholten, Eduard M., Cremers, Serge C.L.M., Schoemaker, Rik C., Rowshani, Ajda T., van Kan, Erik J., den Hartigh, J.A.N., Paul, Leendert C., de Fijter, Johan W.

“…AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipients. Tacrolimus has a narrow therapeutic window, and…”
Get full text

Impact of Late Calcineurin Inhibitor Withdrawal on Ambulatory Blood Pressure and Carotid Intima Media Thickness in Renal Transplant Recipients by Mourer, Jacqueline S, de Koning, Eelco J.P, van Zwet, Erik W, Mallat, Marko J.K, Rabelink, Ton J, de Fijter, Johan W

“…BACKGROUNDCalcineurin inhibitors (CNIs) have an unfavorable cardiovascular risk profile in renal transplant recipients. The aim of this substudy was to assess…”
Get full text

Association Between Mannose‐Binding Lectin Levels and Graft Survival in Kidney Transplantation by Berger, Stefan P., Roos, Anja, Mallat, Marko J.K., Fujita, Teizo, De Fijter, Johan W., Daha, Mohamed R.

“…The mannose‐binding lectin (MBL) pathway of complement is activated by pattern recognition. Genetic MBL variants are frequent and associated with low MBL serum…”
Get full text

Diagnosis of Early Pancreas Graft Failure via Antibody‐Mediated Rejection: Single‐Center Experience With 256 Pancreas Transplantations by de Kort, H., Mallat, M. J. K., van Kooten, C., de Heer, E., Brand‐Schaaf, S. H., van der Wal, A. M., Roufosse, C., Roelen, D. L., Bruijn, J. A., Claas, F. H., de Fijter, J. W., Bajema, I. M.

“…Early pancreas graft loss is usually attributed to technical failure while the possibility of antibody‐mediated rejection (AMR) is generally overlooked. To…”
Get full text